Axogen (NASDAQ:AXGN) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14.29 percent. This is a 40 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $41.378 million which missed the analyst consensus estimate of $41.964 million by 1.40 percent. This is a 12.86 percent increase over sales of $36.664 million the same period last year.
Axogen Q1 2024 Adj EPS $(0.06) Beats $(0.07) Estimate, Sales $41.378M Miss $41.964M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.